Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Specific Membrane Antigen (PSMA) Scan and Multiparametric MRI for Prostate Biopsy Detection of Clinically Significant Prostate Cancer

NCT05820724 is registered in ClinicalTrials.gov with VA Greater Los Angeles Healthcare System as lead sponsor.

NCT NCT05820724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05820724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Specific Membrane Antigen (PSMA) Scan and Multiparametric MRI for Prostate Biopsy Detection of Clinically Significant Prostate Cancer
Lead sponsor
VA Greater Los Angeles Healthcare System
Phase
Phase 2
Overall status
Unknown status
Start date
May 1, 2023
Completion date
May 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer diagnosis